MRI BREAST WITH CONTRAST
Also Known As
Lab Test
₹13200
1K+ people booked this test
🎖️
SENIOR
FLAT 10% OFF FOR SENIOR CITIZENS
👪
FAMILY
ADD A FAMILY MEMBER FOR 20% DISCOUNT
Certified Labs
NABH Accredited
Reports in
6hrs
Measures
No description available
Identifies
No identification information available
60
Mins Home Collection
1M
Happy Customers
4.9
Google Rating
5
Certified Labs
About The Test
What is MRI Breast with Contrast?
An MRI Breast with Contrast is a painless imaging test that uses a strong magnetic field, radio waves, and a safe dye called gadolinium to create highly detailed pictures of the inside of your breast. Unlike X-rays or CT scans, MRI does not use radiation.
How the scan creates detailed breast images
- You lie face-down on a cushioned table with openings for your breasts.
- A special breast coil surrounds the breast to boost signal clarity.
- Gadolinium is injected into a vein; it lights up abnormal areas on the scan.
- Powerful magnets capture hundreds of cross-sectional images in minutes.
List of Parameters
| Parameter | What We Check | Why It Matters |
|---|---|---|
| Enhancement kinetics | How fast & how long an area lights up | Cancer often shows rapid “wash-in & wash-out” curves |
| Lesion morphology | Shape, margins, internal pattern | Irregular spiculated edges raise suspicion |
| Background enhancement | How much normal tissue lights up | High background can hide small cancers |
Why This Test
- Detect early breast cancer in dense tissue
- Accurate staging and treatment planning
- Monitoring for local recurrence after surgery or radiation
When to Take Test
Benefits
Benefits of MRI Breast with Contrast
- High sensitivity for lesions as small as 2–3 mm
- Zero radiation—safe for repeated use
- Complementary to mammography and ultrasound, not a replacement
Illnesses Diagnosed with MRI Breast with Contrast
- Invasive ductal carcinoma
- Ductal carcinoma in situ (DCIS)
- Paget’s disease of the breast
Preparing for test
- Fasting: None required; eat normally unless sedation is planned.
- Medications: Continue usual drugs; bring a list to review.
- Allergies & implants: Notify us of pacemakers, joint replacements, or prior contrast reactions.
- Menstrual timing: Premenopausal women should book days 7–14 of cycle for clearest images.
Pre-requisites
- Renal function test (eGFR) within 30 days
- Previous imaging (mammogram, ultrasound) for comparison
- Signed consent after explanation of risks and benefits
Best Time to Take MRI Breast with Contrast
- Days 7–14 after your period starts (lower hormone-related enhancement)
- At least 6 weeks after biopsy or surgery to reduce inflammation artefacts
Eligibility
- High-risk individuals ≥25 years
- BRCA carriers or first-degree relatives of carriers
- Ineligible if: eGFR <30 mL/min/1.73 m², pregnancy, documented gadolinium allergy
Procedure for MRI Breast with Contrast
- Positioning: Lie face-down; breasts fit into cushioned openings.
- IV line: Contrast is injected halfway through the scan.
- Scan sequences: Multiple 3–6 minute runs totalling 30–45 minutes.
- Monitoring: Intercom keeps you in touch; music is available on request.
Caution Before Taking the Test
- Remove all metal: Jewellery, watches, hairpins, credit cards with magnetic strips.
- Disclose implants: Cochlear, spinal stimulators, or older pacemakers may be contraindicated.
- Arrange a driver if you opt for oral sedation.
Test Results
Results and Interpretations of MRI Breast with Contrast
| Finding / Observation | Description | General Interpretation / Significance |
|---|---|---|
| No enhancement | Tissue remains dark after contrast | Very low likelihood of malignancy |
| Focal mass with rapid wash-out | Bright spot that fades quickly | Suspicious; may need biopsy |
| Non-mass enhancement | Patchy, linear, or segmental bright areas | Could be DCIS; correlate with mammogram |
| Simple cyst | Smooth, round, no enhancement | Benign; routine follow-up |
| Change from Prior Studies | New lesions, size changes, or stability of previously noted findings. | Stability over time is reassuring. New or growing lesions may suggest malignancy and warrant further workup or biopsy. |
| Lymph Node Status | Evaluation of size, shape, cortical thickness, and enhancement of axillary or internal mammary nodes. | Enlarged or abnormally shaped nodes may indicate metastasis or reactive changes. May require ultrasound or biopsy depending on risk profile. |
| Implant Integrity | Assessment for rupture, extracapsular silicone, or other complications (if implants are present). | Identifies intracapsular vs extracapsular rupture, contracture, or implant displacement. MRI is gold standard for implant assessment. |
| BI-RADS Category (0–6) | Standardized classification system guiding follow-up and management. | See detailed breakdown below. |
Risks & Limitations
- Contrast allergy: Rare (≈0.1%); tell us if you have prior reactions to dyes or shellfish.
- Kidney considerations: Gadolinium is removed by the kidneys; we’ll check your eGFR blood test first.
- False positives: MRI may highlight harmless spots, leading to extra tests.
- Claustrophobia: Our wide-bore machine and optional mild sedation keep you comfortable.
- Implant compatibility: Most modern implants are MRI-safe; we verify this beforehand.
FAQs
Is MRI breast with contrast painful?
No. You may feel a cool sensation when the dye is injected, but the scan itself is painless.
How soon will I get results?
Most patients receive their report the next working day.
Can I breastfeed after contrast?
Yes. Current guidelines say breastfeeding can continue normally; less than 0.04 % of gadolinium reaches breast milk.
What if a lesion is found?
Your doctor may recommend additional imaging, MRI-guided biopsy, or short-interval follow-up. Cadabams Diagnostics performs on-site biopsies for faster answers.
Is it covered by insurance?
Most policies cover medically-indicated MRI Breast with Contrast; our front-desk team assists with pre-authorisation.
What happens if an abnormality is found on my MRI Breast with Contrast?
Your doctor will discuss findings. The report includes a BI-RADS assessment. Recommendations include follow-up or biopsy, based on the category.